cardiac-arrest
发表于 2025-3-30 11:39:41
Monoclonal Antibody Studies of Drug Resistance. This multidrug resistance (MDR) involves resistance to some of the most commonly used anticancer drugs. Several mammalian cell lines are available which model this human pleiotropic cross-resistance to chemotherapeutic . agents. These drug-resistant cell lines afford an .. system to study molecula
身体萌芽
发表于 2025-3-30 13:28:09
http://reply.papertrans.cn/47/4622/462172/462172_52.png
placebo
发表于 2025-3-30 19:48:11
Advances Towards Clinical Relevance of Breast Carcinoma Associated Antigensn and identification of free and bound antigenic moieties extracted from breast carcinoma (BC) patients’ sera immune reactants. As a result we have been able to compare and identify reactive similarities encountered with either source of antigens. Both isolated antigens (BCAA), and Mc 3 and Mc 8 mon
Offensive
发表于 2025-3-30 23:49:53
Detection and Assay of the 52K Estrogen-Regulated Protease in Mammary Tumorsaction are not fully understood (1). Monoclonal antibodies to estrogen-regulated antigens in breast cancer may therefore be of interest both as prognostic markers for breast cancer management and as a means of understanding how breast cancer growth is controlled. Antibodies to the estrogen and proge
健忘症
发表于 2025-3-31 04:22:55
http://reply.papertrans.cn/47/4622/462172/462172_55.png
crutch
发表于 2025-3-31 05:23:53
Immunochemical Evaluation of Estrogen Receptor and Progesterone Receptor in Breast Cancer of new quantitative and histochemical immunoassays for these proteins in reproductive tissues and related cancers . Stich assays make use of very specific and sensitive probes that do not depend upon the ability of receptor protein to bind its cognate radiolabeled hormone in tissue extracts.
采纳
发表于 2025-3-31 12:15:21
http://reply.papertrans.cn/47/4622/462172/462172_57.png
Apraxia
发表于 2025-3-31 16:41:49
http://reply.papertrans.cn/47/4622/462172/462172_58.png
machination
发表于 2025-3-31 17:58:13
Immunoaffinity Purification and Structural Analysis of Human Breast Cancer Progesterone Receptors therapies. and as markers of disease aggressiveness.. Development of antibodies specific for human PR and methods for their use in the immunocytochemical detection of receptors in breast tumors would be of value clinically in providing a number of advantages over the biochemical ligand binding assa